öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

ÐÕ Ãû: ÕÅСÓô
Name: Zhang Xiaoyu
Ö° ³Æ£º½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦
Duty: Professor
E-mail£ºzhangxyu@lzu.edu.cn

¿ÆÑз½Ïò

1¡¢²ÉÓù淶µÄϸ°ûºÍ·Ö×ÓÉúÎïѧ/ÉúÀíѧ¼¼Êõ½øÐÐÓйØÉúÀí¡¢Ò©Àíѧ·½ÃæµÄÑо¿¡£
2¡¢²ÉÓÃϸ°ûÐźÅתµ¼¡¢Ñõ»¯Ð²ÆÈÒÔ¼°Ï¸°ûµòÍö¼¼Êõ¶ÔÐÄѪ¹Ü¼²²¡¡¢ÌÇÄò²¡ÒÔ¼°·ÊÅֵȽøÐÐÑо¿¡£
Research Interests£º
1. Work with a major responsibility of physiology and pharmacology using standard cellular and molecular biology/physiology techniques.
2. Focus on cell signaling, oxidative stress, and apoptosis in a number of cardiovascular diseases, diabetes, and obesity.

ÈÙÓþ³ÆºÅ¼°½±Àø£º

1. 2004Äê¸ÊËàÊ¡Ò½ÁÆÎÀÉúÖÐÇàÄêѧÊõ¼¼Êõ´øÍ·ÈË¡£
2. ¡¶ÆÏÌÑ×ÑÖÐÔ­»¨ÇàËض԰¢Ã¹ËØÔöЧ¼õ¶¾×÷Óü°»úÀíÑо¿¡·ÈÙ»ñ2006Äê¸ÊËàÊ¡×ÔÈ»¿Æѧ¶þµÈ½±£¨1/5£©£¬¸ÊËàÊ¡¸ßУ¿Æ¼¼½ø²½Ò»µÈ½±£¨1/8£©£¬À¼ÖÝ´óѧÓÅÐ㲩ʿÂÛÎÄ¡£
3. 2007ÄêÈÙ»ñÀ¼ÖÝ´óѧ¶ÈÊ׽쓡»ùÖÐÇàÄê½Ìʦ½Ìѧ¹Ç¸É½±”£¬»ñµÃ¹ú¼ÒÁôѧ»ù½ðί×ÊÖú×÷Ϊ·ÃÎÊѧÕßÈ¥ÃÀ¹ú½øÐпÆѧÑо¿Ò»Ä꣬Ìá¸ß¿ÆÑÐˮƽ¡£
4. 2011Ä꣬µÚʮһ½ìÈ«¹ú¶àýÌå¿Î¼þ´óÈü¾öÈüÈýµÈ½±£¨µÚÈýÍê³ÉÈË£©
5. 2007Ä꣬ ¡¶ÉúÀíѧÁ¢Ìå½ÌѧģʽµÄ̽Ë÷——ÒÀÍо«Æ·¿Î³ÌÍƶ¯½Ìѧ´´Ð¡· À¼ÖÝ´óѧ½Ìѧ³É¹û¶þµÈ½±£¨µÚËÄÍê³ÉÈË£©
Honors and awards£º
1. In 2004, I won the Discipline Leader on Young and Middle-aged Science and Technology of Public Health Department of Gansu.
2. In 2006, Mechanisms of Proanthocyanidin from Grape Seeds in both Potentiating Anti-tumor Activity and Reducing Toxicity of Doxorubicin obtained the second prize of Gansu Provincial Natural Science, the first prize of scientific and techonology progress in Gansu Provincial advanced colleges and was entitled as the Excellence Doctor Paper in Lanzhou University. (first author).
3. In 2007, I won the prize of the Longji Excellence Teacher in Lanzhou University. At the same time, I got through the academic selection process organized by China Scholarship Council (CSC) and was granted the funds to study abroad for a year.

¸öÈ˼òÀú

ÕÅСÓô£¬Å®£¬²©Ê¿£¬Ë¶Ê¿Éúµ¼Ê¦£¬À¼ÖÝ´óѧ»ù´¡Ò½Ñ§ÔºÒ½Ñ§ÉúÀíѧÑо¿Ëù½ÌÊÚ£¬Ñ§¿Æ´øÍ·ÈË£¬¸ÊËàÊ¡Ò½ÁÆÎÀÉúÖÐÇàÄêѧÊõ¼¼Êõ´øÍ·ÈË£¬ÁôÃÀ·ÃÎÊѧÕß¡£ÖйúÉúÀíѧ»áÏû»¯ÄÚ·ÖÃÚÉúÖ³´úлÉúÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áίԱ£¬¸ÊËàÊ¡ÉúÀíѧ»áÀíÊ¡£
2008Äê12ÔÂÖÁ2009Äê11ÔÂÔÚÃÀ¹úUniversity of WyomingºÍThe State University of Newyork at Buffalo×ö·ÃÎÊѧÕßÆڼ䣬ÀûÓ÷Ö×ÓÉúÎïѧµÈÏȽø¼¼ÊõÊìÁ·ÕÆÎÕÁËÐļ¡È±ÑªÔÙ¹à×¢ËðÉ˱£»¤×÷ÓõÄÊÀ½çÇ°ÑØÑо¿¼¼Êõ£¬·¢±íÏà¹ØSCIÂÛÎÄ3ƪ£»²¢¶ÔISL¿¹Ö×Áö×÷ÓõķÖ×Ó»úÖƽøÐÐÁËϵͳÑо¿£¬ÂÛÎÄ<Natural antioxidant-Isoliquiritigenin selectively inhibits growth of prostate cancer cells>ÒÑÓÚ2010Äê·¢±íÔÚSCI¿¯ÎïClin Exp Physiol PharmÉÏ¡£2006Äê»ñ¸ÊËàÊ¡×ÔÈ»¿Æѧ½ø²½¶þµÈ½±1Ï·¢±í¿ÆÑÐÂÛÎÄ30Óàƪ£¬ÆäÖÐSCIÊÕ¼10Óàƪ¡£Íê³É¸ÊËàÊ¡×ÔÈ»¿ÆѧºÍÀ¼ÖÝÊпƼ¼ÏîÄ¿»ù½ðÏîÄ¿¸÷Ò»ÏĿǰÖ÷³ÖÒ»Ïî¸ÊËàÊ¡×ÔÈ»¿Æѧ»ù½ðÏîÄ¿¡£±¾ÏîÄ¿×÷Ϊ¸ºÔðÈË£¬È«Ã渺Ôð¿ÎÌâµÄ×éÖ¯¡¢¹ÜÀíºÍʵʩ£¬¸ºÔðʵÑéÉè¼Æ¡¢Êý¾ÝÕûÀíºÍ·ÖÎö¡¢ÂÛÎÄ׫д£¬Ö¸µ¼Ä£ÐÍÖÆ×÷ºÍ·Ö×ÓÉúÎïѧ¼ì²â¡£
1. 1983Äê9ÔÂÖÁ1998Äê7Ô ÔÚÔ­À¼ÖÝҽѧԺÁÙ´²Ò½Ñ§Ïµ¹¥¶Á±¾¿Æ¡£
2. 1996Äê9ÔÂÖÁ1999Äê7Ô ÔÚÔ­À¼ÖÝҽѧԺҩÀíѧ¹¥¶Á˶ʿ¡£
3. 2002Äê9ÔÂÖÁ2005Äê6Ô ÔÚÀ¼´óÉúÃü¿ÆѧѧԺ¶¯ÎïÉúÀíѧ¹¥¶Á²©Ê¿¡£

¹¤×÷¾­Àú

1. 1998Äê9ÔÂÖÁ1996Äê7Ô ÔÚÀ¼Íϳ§Ò½ÔºÈÎÖ÷ÖÎҽʦ¡£
2. 1999Äê7ÔÂÖÁ2000Äê6Ô ÔÚÔ­À¼ÖÝҽѧԺÉúÀíѧ½ÌÑÐÊÒÈÎÖú½Ì¡£
3. 2000Äê7ÔÂÖÁ2002Äê6Ô ÔÚÔ­À¼ÖÝҽѧԺÉúÀíѧ½ÌÑÐÊÒÈν²Ê¦¡£
4. 2002Äê7ÔÂÖÁ2004Äê11Ô ÔÚÔ­À¼ÖÝҽѧԺÉúÀíѧ½ÌÑÐÊÒÈθ±½ÌÊÚ¡£
5. 2004Äê11ÔÂÖÁ2008Äê5Ô ÔÚÀ¼ÖÝ´óѧ»ù´¡Ò½Ñ§ÔºÉúÀíѧÑо¿ËùÈθ±½ÌÊÚ¡£
6. 2008Äê5ÔÂ---ÖÁ½ñÔÚÀ¼ÖÝ´óѧ»ù´¡Ò½Ñ§ÔºÉúÀíѧÑо¿ËùÈνÌÊÚ¡£
7. 2008Äê12ÔÂÖÁ2009Äê12Ô ÔÚÃÀ¹ú»³¶íÃ÷´óѧ×ö·ÃÎÊѧÕß¡£

Resume
1. Sept. 2002--- June 2005Ph.D. in Physiology, the Life Science School of Lanzhou University, Lanzhou 730000, Gansu, P.R.China.
2. Sept. 1996--- June 1999M.S. in Pharmacology, the Department of Pharmacology of Lanzhou Medical College, Lanzhou 730000, Gansu, P.R.China.
3. Sept. 1983---July 1988 B.S. in Clinical Medicine, the Department of Clinical Medicine of Lanzhou Medical College, Lanzhou 730000, Gansu, P.R.China.
Working Experiences
1. Dec. 2008--- Dec. 2008 visiting scholar in University of Wyoming, USA
2. May 2008---NowProfessor, Institute of Physiology£¬School of Basic Medicine Science, Lanzhou University, Lanzhou 730000, Gansu, P.R.China
3. Nov. 2004--- May 2008Associate Professor, Institute of Physiology£¬School of Basic Medicine Science, Lanzhou University, Lanzhou 730000, Gansu, P.R.China
4. July 2002--- Nov. 2004Associate Professor, Department of Physiology, Lanzhou Medical College, Lanzhou 730000, Gansu, P.R.China
5¡¢Oct. 2000---July 2002Lecturer, Department of Physiology, Lanzhou Medical College, Lanzhou 730000, Gansu, P.R.China
6. July 1999---Oct. 2000 Assistant£¬Department of Physiology, Lanzhou Medical College, Lanzhou 730000, Gansu, P.R.China
7. Sept. 1988--- July 1996 Attending physician, Hospital of Lanzhou Tractor Factory, Lanzhou 730050, Gansu, P.R.China

Ö÷³ÖµÄ¿ÆÑÐÏîÄ¿£º

1. Ö÷³Ö¸ÊËàÊ¡Ê¡×ÔÈ»¿ÆѧÑо¿»ù½ð¼Æ»®ÏîÄ¿Ò»Ï1208RJZA231£©£¬Òì¸Ê²ÝËØ¿¹Ö×ÁöѪ¹ÜÉú³ÉµÄ»úÖÆÑо¿£¬2012.1-2014.12
2. Ö÷³Ö¸ÊËàÊ¡Ê¡×ÔÈ»¿ÆѧÑо¿»ù½ð¼Æ»®ÏîÄ¿Ò»Ï0710RJZA037£©£¬Ï¡ÍÁÅäºÏÎÖ×Áö×÷Ó÷Ö×Ó»úÀíÑо¿£¬2008.1-2009.12
3. Ö÷³ÖÀ¼ÖÝÊпƼ¼¼Æ»®×ÊÖúÏîÄ¿Ò»Ï1208RJZA231£©Òì¸Ê²ÝËØ¿¹Ö×ÁöѪ¹ÜÉú³ÉµÄ»úÖÆÑо¿£¬2007.1-2008.12
4. Ö÷³ÖÆóÊÂÒµµ¥Î»Î¯ÍÐÏîÄ¿£¬Îì¸ÎÒßÃçÁÙ´²Ç°Öظ´¸øÒ©£¬¶¾ÐÔÊÔÑ飬2005.11-2007.6
5. Ö÷³ÖÆóÊÂÒµµ¥Î»Î¯ÍÐÏîÄ¿£¬ÉßÆÏÌÑËØ¿¹Ö×Áö×÷ÓõÄÑо¿£¬2006.4-2007.12
6. Ö÷³ÖÀ¼ÖÝ´óѧҽѧ»ù½ðÒ»ÏϡÍÁÅäºÏÎÖ×Áö×÷Óü°»úÀíÑо¿£¬2007.1-2008.12
7. Ö÷³Ö¸ÊËàÊ¡ÐÂÒ©ÁÙ´²Ç°Ñо¿ÖصãʵÑéÊÒ¿ª·Å¿ÎÌâ»ù½ðÒ»Ï¶þ£¨2-ßÁऻù-N-Ñõ»¯Î¶þÁò»¯ÎïïçÏ¡ÍÁÅäºÏÎïµÄ¿¹Ö×Áö×÷Óü°»úÀíÑо¿£¬2006.1-2008.12
²ÎÓë¿ÆÑÐÏîÄ¿Çé¿ö£º
1. ÒÔÏîÄ¿×éÖ÷Òª³ÉÔ±£¨2/9£©²ÎÓë¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðί——ÃæÉÏÏîÄ¿Ò»ÏÌî³äÎü¸½Î¢Á¿ÝÍÈ¡·¨½áºÏϸ°û´úл×éѧÑо¿½ðÄÉÃײÄÁϵĶ¾ÐÔ£¬2014.1-2017.12
2. ÒÔÏîÄ¿×éÖ÷Òª³ÉÔ±£¨2/4£©²ÎÓë¸ÊËàÊ¡×ÔÈ»»ù½ðÏîÄ¿Ò»Ï¿¹²¡¶¾Ò©É¸Ñ¡Ä£Ð͵Ľ¨Á¢¼°¿¹²¡¶¾ÖÐÒ©£¬2004.7-2006.12

·¢±íÂÛÎÄ

Publications
1. Xiaoyu Zhang, Ping Zhu, Xiuying Zhang, Yina Ma, Wenguang Li, Ji-Mei Chen,Hui-Ming Guo, Richard Bucala, Jian Zhuang, and Ji Li. Natural Antioxidant-Isoliquiritigenin Ameliorates Contractile Dysfunction of Hypoxic Cardiomyocytes via AMPK Signaling Pathway. Mediators of Inflammation. Volume 2013, Article ID 390890, 10 pages.(SCI, IF2013 = 3.882)
2. XiaoYu ZHANG, WenGuang LI, YongJie WU, TianZhen ZHENG, Wei LI, SongYi QU and NaiFa LIU. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int. Immunopharmacol. 2005; 5(7-8): 1247–1257. (SCI)
3. XiaoYu ZHANG, WenGuang LI, YongJie WU, DeCheng BAI, and NaiFa LIU. Proanthocyanidin from grape seeds enhances doxorubicin-induced anti-tumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells. Can. J. Physiol. Pharmacol. 2005; 83(3): 309–318. (SCI)
4. XiaoYu ZHANG, WenGuang LI, YongJie WU and MingTang GAO. Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumor-bearing mice. J. Pharmacy Pharmacol. 2005: 57(8): 1043–1052. (SCI)
5. Xiaoyu ZHANG, Decheng BAI, Yongjie WU, Wenguang LI and Naifa LIU. Proanthocyanidin from grape seeds enhances anti-tumor effect of doxorubicin both in vitro and in vivo. Pharmazie. 2005; 60(7): 533–538. (SCI)
6. XiaoYu ZHANG, WenGuang LI, YongJie WU and Xuan TIAN. Antioxidative and antitumor activity of spin labeled derivatives of 4-β-amino-4'-demethylepipodophyllotoxin and their structure-activity relationship. Pharmazie. 2007; 62(6): 432–438. (SCI)
7. Xiaoyu Zhang, Jingying Wang, Wenguang Li, Ji Li. Natural Antioxidant-Isoliquiritigenin Protects Heart against Ischemia-Reperfusion Injury via Activation of Cardioprotective Signaling Pathways. Circulation. 2009;120:S1445.(Abstract) (SCI)
8. Xiaoyu Zhang, Eddie D Yeung, Jingying Wang, Evgeniy E Panzhinskiy, Tong Chao, Wenguang Li, Ji Li. Natural antioxidant-Isoliquiritigenin selectively inhibits growth of prostate cancer cells. Clin. Exp. Physiol. Pharm. 2010; 37: 841–847 (SCI)
9. WenGuang LI, XiaoYu ZHANG, YongJie WU, MingTang GAO and Rongliang ZHENG.. The relationship between structure and antioxidative activity of piperidine nitroxides. J. Pharm. Pharmacol. 2006; 58(7): 941–949. (SCI)
10.LI Wenguang, ZHANG XiaoYu, WU YongJie and TIAN Xuan. Antioxidative activity of spin labelled derivatives of podophyllilic acid hydrazide. Acta Pharmacol. Sin. 2002; 23(8): 727–732. (SCI)
11.LI Wenguang, ZHANG XiaoYu, WU YongJie and TIAN Xuan. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol. Sin. 2001; 22(12): 1117-1120. (SCI)
12.ZHANG XiaoYu, ZHENG TianZhen and PANG JinJiang. Effects of progesterone on contractile activity of trachea smooth muscle in rabbits. Chin J Appl Physiol. 2003; 19(4): 388, 401. (CSCD)
13.ZHANG XiaoYu, LI WenGuang, ZHENG TianZhen and LI¡¡£×ei. Effects of proanthocyanidins on contractile activity of aortic smooth muscle and platelet aggregation in experimental animals. Chin J Appl Physiol. 2005; 21(4): 383-386. (CSCD)
14.ZHANG XiaoYu, LI WenGuang, GAO MingTang and TIAN Xuan. Protectective effect on injured myocardial cells of proanthocyanidins in vitro. Pharmacol Clin Chin Materia Med. 2001; 17(6): 14-16 (CSCD)
15.ZHANG XiaoYu, GAO MingTang, LI WenGuang, TIAN Xuan and ZHU JuHua. The anti-lipoperoxidative effect of grape seed extract in vitro. Advanced in Free Badical Life Sciences. 1999; 7: 116-120.
16.ZHANG XiaoYu, ZHANG YongPing and LI WenGuang. Anti-tumor activity of lanthanum nitrate Complexes with bis(2-pyridyl-N-Oxide)disulphide in vitro. J Lanzhou University ( Natural Sci). 2004; 40Supp: 34–36. (CSCD)
17.ZHANG XiaoYu, LI WenGuang, WU YongJie and GAO MingTang. CHL chromosome aberration test of proanthocyanidinsfrom grape seeds. J Lanzhou University ( Natural Sci). 2002; 38(6) Supp: 15-17. (CSCD)
18.Xiaoyu Zhang, Jingying Wang, Wenguang Li, Ji Li. Natural Antioxidant-Isoliquiritigenin Protects Heart against Ischemia-Reperfusion Injury via Activation of Cardioprotective Signaling Pathways. Circulation. 2009;120:S1445.(Abstract)
19.Tuanming YANG, ShiFang GUO, Changrui CHENG, XiaoYu ZHANG and Wenguang LI. Anti-osteosarcoma effects and mechanisms of 4-O-amino-phenol-4′-demethylepipodophyllotoxin ether. J. Pharm. Pharmacol. 2008£»60(2): 179-188. (SCI)
20.Zheng-lan Han, Zi-long Wang, Hong-zhu Tang, Ning Li, Quan Fang*, Xu-hui Li, Xiong-li Yang, Xiao-yu Zhang, Rui Wang* .Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice. Behav Brain Res. 2013; 248; 51-56. (SCI)
21.SI JinChao, ZHANG XiaoYu, LIN MeiLing, DING YongHui, LI Mei, QU SongYi and ZHENG TianZhen. Effects of Ephedra on body mass, serum lipid, glucose and hormone level of ovarietomized obese rats. Chin J Clin Rehabilit. 2006; 10(47): 209–212. (CSCD)
22.LI WenGuang, ZHANG XiaoYu and WU YongJie. Effect of podophyllic acid hydrozide piperidingyloxy and its derivatives on MDA formation. Chin Pharmacol Bull. 1997; 13(5): 422-424. (CSCD)
23.Jingying Wang, Heng Ma, Xiaoyu Zhang, Leilei He, Jianming Wu, Xiaoping Gao, Jun Ren, Ji Li. A Novel AMPK Activator from Chinese Herb Medicine and Ischemia Phosphorylate the Cardiac Transcription Factor FOXO3. Int J Physiol Pathophysiol Physiol. 2009: 1: 116-126 (SCI)
24.Peng Zhao, Jingying Wang, Leilei He, Heng M, Xiaoyu Zhang, Xinglei Zhu, E. Kurt Dolence, Jun Ren, Ji Li. Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia. J. Cell. Mol. Med. 2009; 13: 1513–1525 (SCI)
25.Wang Jun, Wang Hao, Guo Zhen, ZHANG XiaoYu, QU SongYi and ZHENG TianZhen. Gastrodin in modulating body mass and metabilism in obese rats fed with high-fat diet. J Clin Rehabilit. Tissue Engineering Res. 2008; 12(207): 3992–3996. (CSCD)
26.Guo Jiaohong, Li Xujun, Yue Jia, ZHANG XiaoYu, Lin Meiling and ZHENG TianZhen. The effects of Radix Achykanthis Bidentatae from Henan of China on body weight and tumor Necrosis Factor-α in ovariectomized obese rats. J Chengdu Medical College 2008; 3(2): 100–102, 106.
27.Li Xujun, Yue Jia, Chang Yanqin, Lin Meiling, ZHANG XiaoYu, Ding Yonghui and ZHENG TianZhen. Effects of Rhizoma Wenyujin Concisum on ovariectomized obese rats. China J Modern Med. 2008; 18(4): 405–407, 412. (CSCD)
28.Ô¬Á¼½Ü£¬Â¬Ï¼£¬Íõ¾ý£¬Ö£ÌìÕ䣬öÄËÌÒ壬ÕÅСÓô*. ¿à²Î¼î¶Ô¸ßÖ¬·ÊÅÖ´óÊóÌåÖØ¡¢ÑªÖ¬ºÍ¿¹¹ýÑõ»¯ÄÜÁ¦µÄÓ°Ïì. ʱÕä¹úÒ½¹úÒ©. 2008; 19£¨9£©: 2062-2064£¨*ΪͨѶ×÷Õߣ©(CSCD)
29.°× ÑÒ£¬Â¬Îéµ³£¬ÀîÎĹ㣬ÕÅСÓô*. ½ðÊôÅäºÏÎïCu(¢ò)1-ôÇ»ù-3-£¨2-»·Ñõ»ù£©¶ÖͪµÄÌåÍ⿹Ö×Áö×÷ÓÃ. À¼ÖÝ´óѧѧ±¨£¨Ò½Ñ§°æ£©. 2010; 36(2): 56-60 £¨*ΪͨѶ×÷Õߣ©
30.°× ÑÒ£¬Â¬Îéµ³£¬ÀîÎĹ㣬ÕÅСÓô*. ½ðÊôÅäºÏÎïCu(¢ò)¶Öͪ¹ÚÃѵÄÌåÍ⿹Ö×Áö×÷ÓÃ. À¼ÖÝ´óѧѧ±¨£¨Ò½Ñ§°æ£©. 2010; 36(3): 21-25£¨*ΪͨѶ×÷Õߣ©
31.»ÆÕ÷£¬ÕÅÁÖ£¬öÄËÌÒ壬 Ö£ÌìÕ䣬ÕÅСÓô*. ÌìÂéËضԴóÊóÀëÌåÖ¬·¾×éÖ¯ÊÍ·ÅÓÎÀëÖ¬·¾Ëá¼°¿¹Ñõ»¯×÷ÓõÄÓ°Ïì. µÚËľüÒ½´óѧѧ±¨(J. Fourth Mil. Univ.). 2009£º30£¨16£©£º1488-1490. £¨*ΪͨѶ×÷Õߣ©(CSCD)
32.Öì¼Ò¶÷£¬°×ÑÓ±ó£¬ÝþÃÀÁᣬ֣ÌìÕ䣬öÄËÌÒ壬¶¡ÓÀ»Ô£¬ÕÅСÓô*.°×ÉÖ¶ÔÈ¥Âѳ²´óÊóÌåÖØ¡¢ÑªÖ¬¼°¿¹Ñõ»¯ÄÜÁ¦µÄÓ°Ïì.ÖйúÀÏÄêѧÔÓÖ¾£¬2009, 29(2): 135-137 £¨*ΪͨѶ×÷Õߣ©(CSCD)
33.ÕÔÀö£¬³Âºì÷£¬ÝþÃÀÁᣬÁõÊÀÐÛ£¬ÀîÖÐƽ£¬Íõ־ǿ£¬ÕÅСÓô*£¬Ö£ÌìÕä.Ô­»¨ÇàËضÔSTZÖÂÒȵºÏ¸°ûËðÉ˵ı£»¤×÷ÓÃ. ÖйúÀÏÄêѧÔÓÖ¾£¬2011, 31(23): 4580-4582 £¨*ΪͨѶ×÷Õߣ©(CSCD)
34.ÀîÖÐƽ£¬ÈÎÎĻԣ¬Õű¦Àö£¬ÝþÃÀÁᣬ³Âºì÷£¬ÕÔÀö£¬Íõ־ǿ£¬ÕÅСÓô*.éÄÀƼî¶ÔSTZÖÂINS-1ϸ°ûËðÉ˵ı£»¤ºÍÐÞ¸´×÷ÓÃ. ÖйúÀÏÄêѧÔÓÖ¾£¬2011, 31(23): 4583-4585 £¨*ΪͨѶ×÷Õߣ©(CSCD)
35.Íõ־ǿ£¬»ÆË«Ê¢£¬ÁõÔ²Ô²£¬ºúÀ°Ã·£¬ÀîÎĹ㣬ºî´äÀ¼, ÕÅСÓô*¡£Òì¸Ê²ÝËصĿ¹Ö×ÁöѪ¹ÜÉú³É×÷ÓÃ.Öйú¿Æ¼¼ÂÛÎÄÔÚÏß, 2012£¨*ΪͨѶ×÷Õߣ©

ѧÊõ¼æÖ°£º

ÖйúÉúÀíѧ»áÏû»¯ÄÚ·ÖÃÚÉúÖ³´úлÉúÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á ίԱ
¸ÊËàÊ¡ÉúÀí¿Æѧѧ»á ÀíÊÂ
¸ÊËàÊ¡ÐÂÒ©ÁÙ´²Ç°Ñо¿ÖصãʵÑéÊÒ ³ÉÔ±